Hypothesis: Age‑associated shifts in the gut microbiome create a microbial aging clock that raises circulating δ‑valerobetaine and primes microglial NLRP3 inflammasome activity, linking microbial senescence to cognitive decline.
The gut microbiota of older individuals shows a reproducible increase in Parabacteroides goldsteinii and a loss of butyrate‑producing taxa such as Akkermansia muciniphila ([1][2]). Beyond altered metabolite ratios, we propose that these taxa undergo intrinsic age‑related changes—evidenced by shifts in microbial DNA methylation patterns and reduced replication fidelity—that functionally age the microbial community independent of host chronology. This microbial aging clock elevates production of δ‑valerobetaine, a tryptophan‑derived metabolite known to rise with host age and to suppress hippocampal neurogenesis ([3]).
We further hypothesize that δ‑valerobetaine acts not only as a passive biomarker but as an active signaling molecule that crosses the blood‑brain barrier and engages microglial Toll‑like receptor 4 (TLR4) signaling, leading to NF‑κB‑mediated transcription of NLRP3 and pro‑IL‑1β. Simultaneously, the depletion of butyrate‑producing strains reduces histone deacetylase inhibition in microglia, favoring a hyperacetylated state that sensitizes the NLRP3 inflammasome to δ‑valerobetaine priming. The combined effect is a lowered threshold for inflammasome activation upon secondary stimuli (e.g., ATP or crystalline uric acid), resulting in exaggerated IL‑1β release, synaptic phagocytosis, and impaired long‑term potentiation in the hippoc





























